LYBALVI 5 mg / 10 mg Oral Tablet
RxNorm 2570398
Concept Hierarchy & Relationship Mapping
RxNorm Concept Unique Identifier (RxCUI) 2570398 represents a standardized clinical drug concept used for cross-system interoperability. This concept aggregates multiple Atom IDs (AUIs), which are specific naming variations and synonyms used across pharmaceutical databases to ensure accurate medication mapping for: LYBALVI 5 mg / 10 mg Oral Tablet.
The following semantic concepts and normalized strings are associated with this clinical entity:
This clinical crossover tool is designed for healthcare professionals, pharmacists, and data analysts to safely compare substitute products and manage medication interoperability.
SYPrescribable
Synonym (SY):
Lybalvi (olanzapine 5 mg / samidorphan 10 mg (as samidorphan L-malate 13.6 mg)) Oral Tablet
(Atom ID: 12684904)
TMSYPrescribable
Tall Man Lettering Synonym (TMSY):
Lybalvi (OLANZapine 5 mg / samidorphan 10 mg (as samidorphan L-malate 13.6 mg)) Oral Tablet
(Atom ID: 12686220)
SYPrescribable
Synonym (SY):
Lybalvi (olanzapine 5 mg / samidorphan 10 mg) Oral Tablet
(Atom ID: 12684903)
TMSYPrescribable
Tall Man Lettering Synonym (TMSY):
Lybalvi (OLANZapine 5 mg / samidorphan 10 mg) Oral Tablet
(Atom ID: 12686233)
PSNPrescribable
Prescribable Name (PSN):
LYBALVI 5 mg / 10 mg Oral Tablet
(Atom ID: 12684908)
SBDPrescribable
Semantic Branded Drug (SBD):
Olanzapine 5 mg / samidorphan 10 mg Oral Tablet [Lybalvi]
(Atom ID: 12684902)
TMSYPrescribable